This test is most useful if any of these apply to you.
If you have urethral burning or discharge and a standard sexually transmitted infection panel came back clean, this test looks for an organism that panel likely skipped. It detects a bacterium that ordinary urine tests and cultures usually miss entirely.
The catch is that finding it does not automatically mean it is causing your problem. Many healthy people carry it with no symptoms, so the result only matters when read alongside your symptoms, sex, and situation.
Ureaplasma urealyticum (its name reflects that it feeds on urea, a waste product carried in urine) is one of the smallest free-living bacteria known. Unlike most bacteria, it has no outer wall, which is why it cannot be seen on a standard stained slide and will not grow on the usual laboratory plates.
This test finds the organism's genetic material in your urine using a method that copies and identifies specific DNA sequences, called PCR (polymerase chain reaction). Because the organism slips past routine microbiology, a normal urine test or standard culture does not rule it out. It survives by breaking down urea into ammonia, which is both how it gets energy and part of how it can irritate tissue.
Detection alone is common and often harmless. Ureaplasma species as a group colonize up to 40 to 80 percent of sexually active women; Ureaplasma urealyticum specifically is found in roughly 10 to 30 percent of women and a smaller share of men, usually with no symptoms at all. That is the single most important fact for interpreting your result: a positive test is frequent even in perfectly healthy people. Because carriage is so common, professional guidelines do not recommend routine testing of people without symptoms.
In research settings, higher amounts of the organism are treated as more likely to reflect a true infection, while very low amounts are usually treated as harmless carriage. That is why the number of organisms detected, not just a yes or no, helps separate a nuisance finding from a meaningful one.
The strongest evidence that this organism causes disease is in men with urethral inflammation not caused by gonorrhea or chlamydia, a condition called nongonococcal urethritis. A meta-analysis pooling seven studies found this organism, but not its close relative Ureaplasma parvum, showed up significantly more often in men with the condition than in men without it.
In a study of about 700 men, the link was strongest among those with fewer lifetime sexual partners. Men with fewer than five partners who carried it had roughly five to six times the odds of urethritis compared with controls. Other work has found that the amount of organism present tracks with the degree of inflammation, with higher urine loads linked to higher white blood cell counts, a direct sign of inflammation. Not every study agrees that the organism causes urethritis, though: one well-designed case-control study found it on its own was no more common in affected men than in controls, and current CDC guidance describes the evidence as inconsistent.
The fewer-partners finding runs against the usual assumption that more partners means more risk. The explanation is that this is not a simple more-exposure-equals-more-disease bug. Repeated exposure appears to build partial immune tolerance, so the organism may cause more visible trouble in people meeting it for the first time than in those exposed many times. This remains a hypothesis rather than proven mechanism.
Among men being evaluated for infertility, carriage is common and has been tied to lower semen quality. In one large cohort, men positive for the organism had higher sperm DNA fragmentation, a measure of genetic damage inside sperm. Separate work linked male infection to higher levels of inflammatory signals in semen (including TNF, IL-1beta, and IL-6, all markers of an active immune response) and to poorer sperm movement and count.
The picture is not settled. One meta-analysis found no significant link between this organism and female infertility, and a large infertility cohort found male carriage had minimal effect on in vitro fertilization success or newborn outcomes. Treat a positive result here as one piece of a fertility workup, not a verdict.
In pregnancy the organism has been associated with preterm birth, early rupture of the membranes, low birth weight, and miscarriage. Pooled analyses put the increased odds of preterm birth at roughly 1.5 to 1.8 times, though some meta-analyses that group Ureaplasma species together report higher figures. Major reviews stress that this evidence cannot prove cause and effect, because colonization is so common and studies rarely control well for other factors.
The signal is clearest in newborns. In a study of 227 preterm infants, those whose urine tested positive had a severe complication rate of 24.4 percent versus 8.7 percent in negative infants, and infants positive in both urine and placenta had the highest rate at 28.1 percent. Detection in deeper sites like amniotic fluid or placenta carries more weight than a urine result alone.
In people with weakened immune systems the stakes change sharply. After organ transplantation, especially lung transplant, this organism can trigger a dangerous buildup of ammonia in the blood (hyperammonemia syndrome) that can injure the brain, and it has been linked to graft loss and death. This is rare and documented mostly in case reports, but it is why transplant teams treat a positive result as urgent rather than incidental.
A single positive tells you the organism is present today, not whether it is driving disease or will clear on its own. If you test positive and get treated, a follow-up test several weeks after finishing antibiotics is worth doing, because resistance to commonly used antibiotics does occur and confirms the organism actually cleared.
There is no case for repeatedly testing an asymptomatic person who has already been evaluated. A sensible rhythm is to test when you have a specific reason (symptoms, a fertility workup, or a partner's diagnosis), retest to confirm cure after treatment, and otherwise not chase the number.
A positive result should not be acted on alone. Order it alongside tests for chlamydia, gonorrhea, and trichomonas, since these are more established causes of the same symptoms and often need addressing first. Checking white blood cells in the urine helps show whether real inflammation is present or the organism is just along for the ride.
The combination of findings guides the decision. A positive result plus urethral symptoms plus elevated urine white cells, with other infections excluded, points toward treatment. A positive result with no symptoms and a clean inflammation check usually points toward watchful waiting. If you are pregnant, planning pregnancy, or immunocompromised, bring the result to a clinician who can weigh it against your specific situation, since those contexts change the meaning entirely.
Evidence-backed interventions that affect your Ureaplasma urealyticum level
Ureaplasma urealyticum is best interpreted alongside these tests.
Ureaplasma urealyticum is included in these pre-built panels.